
MDFA is Australia’s largest source of research funding in the field of macular disease outside of government
Read MoreComposition and functionality of high-density lipoprotein in age-related macular degeneration and a high-risk disease phenotype
Read MoreRedefining macular disease diagnosis to improve access to emerging therapies
Read MoreInvestigating mitochondrial dysfunction in macular degeneration – towards new treatments and biomarkers
Read MoreEvaluating the potential of hyperspectral imaging for detecting and monitoring geographic atrophy Accurate monitoring of
Read MoreVabysmo is a new treatment for age-related macular degeneration and diabetic macular oedema and is now available on the Pharmaceutical Benefits Scheme (PBS) in Australia
Read MoreWe aim to respond to your request by the next business day. If you require assistance sooner, please call our National Helpline on 1800 111 709 (Monday - Friday 9-5pm AEST).
If your query is about an eye emergency - including sudden changes to your vision or eye pain - please contact your optometrist or ophthalmologist as soon as possible.
Great!